Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Wave Life Sciences Ltd. (NASDAQ: WVE).

Full DD Report for WVE

You must become a subscriber to view this report.


Recent News from (NASDAQ: WVE)

Pfizer's pain is DMD players' gain
Pfizer's decision to bail on DMD candidate domagrozumab has stoked buying in other companies developing treatments for Duchenne muscular dystrophy (DMD). More news on: Sarepta Therapeutics, Inc., Wave Life Sciences, Catabasis Pharmaceuticals, Healthcare stocks news, Stocks on the move, ...
Source: SeekingAlpha
Date: August, 30 2018 12:43
Pfizer bails on DMD candidate domagrozumab
Pfizer (NYSE: PFE ) is terminating development of domagrozumab (PF-06252616) for the treatment of Duchenne muscular dystrophy (DMD) after a Phase 2 study (B5161002) failed to achieve the primary endpoint of the mean change from baseline in 4 Stair Climb (in seconds) versus placebo after on...
Source: SeekingAlpha
Date: August, 30 2018 08:47
Wave Life receives US Orphan Drug and Rare Pediatric Disease Designations for WVE-210201
The FDA has granted both Orphan Drug and Rare Pediatric Disease Designations to Wave Life Sciences' (NASDAQ: WVE ) WVE-210201 for the treatment of Duchenne muscular dystrophy. The European Commission previously granted orphan drug designation for WVE-210201 in July. More news on: Wave Li...
Source: SeekingAlpha
Date: August, 16 2018 08:49
Wave Life Sciences Receives US Orphan Drug and Rare Pediatric Disease Designations for WVE-210201
CAMBRIDGE, Mass., Aug. 16, 2018 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ: WVE), a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined diseases, today announced that the U.S. Food and Drug Administration (FDA) has g...
Source: GlobeNewswire
Date: August, 16 2018 08:00
Wave Life Sciences up 5% premarket on Q2 results
Wave Life Sciences ( WVE ) Q2 results : Revenues: $4.9M. More news on: Wave Life Sciences, Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...
Source: SeekingAlpha
Date: August, 09 2018 08:42
Wave Life Sciences misses by $0.68, misses on revenue
Wave Life Sciences (NASDAQ: WVE ): Q2 EPS of -$1.23 misses by $0.68 . More news on: Wave Life Sciences, Earnings news and commentary, Stocks on the move, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: August, 09 2018 08:14
Wave Life Sciences Reports Second Quarter 2018 Financial Results and Provides Business Update
CAMBRIDGE, Mass., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ: WVE), a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined diseases, today announced financial results for the second quarter ended June 30...
Source: GlobeNewswire
Date: August, 09 2018 08:00
Biogen slump pressures other biotechs
Biogen's ( BIIB -8.9% ) post-BAN2401 data-stoked drop appears to be affecting some of the other Alzheimer's players. More news on: Biogen Inc., SPDR Biotech ETF, Eisai Co., Ltd. ADR, Healthcare stocks news, Stocks on the move, News on ETFs, Read more ...
Source: SeekingAlpha
Date: July, 26 2018 10:32
Capricor up 5% ahead of DMD study update
Thinly traded nano cap Capricor Therapeutics ( CAPR +5.2% ) is up on a 5x surge in volume. Shares have rallied over  12%  since Tuesday. More news on: Capricor Therapeutics, Inc., Sarepta Therapeutics, Inc., PTC Therapeutics, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: July, 13 2018 10:26
Alzheimer's players in the green on Biogen news
Most players in the Alzheimer's disease space are in the green after Biogen announced positive mid-stage data on BAN2401. More news on: vTv Therapeutics, Tonix Pharmaceuticals Holding Corp., ACADIA Pharmaceuticals Inc., Healthcare stocks news, Stocks on the move, Read more ...
Source: SeekingAlpha
Date: July, 06 2018 10:12

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-0849.8549.9551.6049.6083,609
2018-05-1741.4543.0544.2041.45186,738
2017-03-1027.2026.9527.2026.802,845
2017-03-0927.3027.0027.3026.3051,074
2017-03-0827.1027.0027.3026.4052,186

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1316,48426,12363.1015Short
2018-12-1213,26527,78947.7347Short
2018-12-1113,29832,76740.5835Short
2018-12-1015,08119,69476.5766Short
2018-12-0716,23322,69471.5299Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on WVE.


About Wave Life Sciences Ltd. (NASDAQ: WVE)

Logo for Wave Life Sciences Ltd. (NASDAQ: WVE)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $1,097,295,965 - 05/11/2018
  • Issue and Outstanding: 27,992,244 - 03/01/2018

 


Recent Filings from (NASDAQ: WVE)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 09 2018
Amendment to a previously filed 10-K
Filing Type: 10-K/AFiling Source: edgar
Filing Date: May, 09 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 09 2018
Amendment to a previously filed 10-K
Filing Type: 10-K/AFiling Source: edgar
Filing Date: April, 27 2018
Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: April, 26 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 10 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 26 2018
Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: March, 22 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 12 2018

 

 


Daily Technical Chart for (NASDAQ: WVE)

Daily Technical Chart for (NASDAQ: WVE)


Stay tuned for daily updates and more on (NASDAQ: WVE)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: WVE)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in WVE is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of WVE and does not buy, sell, or trade any shares of WVE. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/